US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
CA2523083C
(en)
|
2003-04-25 |
2014-07-08 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
PT1778251E
(pt)
|
2004-07-27 |
2011-06-29 |
Gilead Sciences Inc |
Análogos de fosfonato de compostos inibidores de vih
|
EP1852434B1
(en)
|
2005-02-21 |
2011-07-13 |
Shionogi Co., Ltd. |
Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
|
EP3372281B1
(en)
|
2005-04-28 |
2021-07-07 |
VIIV Healthcare Company |
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
|
JP2006342115A
(ja)
|
2005-06-10 |
2006-12-21 |
Shionogi & Co Ltd |
Hivインテグラーゼ阻害活性を有する多環性化合物
|
EP1910363A4
(en)
|
2005-08-04 |
2010-05-26 |
Glaxosmithkline Llc |
INHIBITORS OF HIV INTEGRASE
|
AU2006306355A1
(en)
|
2005-10-27 |
2007-05-03 |
Merck & Co., Inc. |
HIV integrase inhibitors
|
US8188271B2
(en)
|
2005-10-27 |
2012-05-29 |
Shionogi & Co., Ltd. |
Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
|
TW200811153A
(en)
|
2006-06-23 |
2008-03-01 |
Japan Tobacco Inc |
6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
|
JP2009543867A
(ja)
|
2006-07-17 |
2009-12-10 |
メルク エンド カムパニー インコーポレーテッド |
抗hiv剤としての1−ヒドロキシナフチリジン化合物
|
US20100216834A1
(en)
|
2006-10-18 |
2010-08-26 |
Isaacs Richard C A |
Hiv integrase inhibitors
|
EA201200631A1
(ru)
|
2007-11-16 |
2012-11-30 |
Джилид Сайенсиз, Инк. |
Ингибиторы репликации вируса иммунодефицита человека
|
AU2008346833B2
(en)
|
2008-01-08 |
2014-07-17 |
Merck Sharp & Dohme Corp. |
Process for preparing N-substituted hydroxypyrimidinone carboxamides
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
WO2009154870A1
(en)
|
2008-05-05 |
2009-12-23 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
US8426405B2
(en)
|
2008-07-02 |
2013-04-23 |
Avexa Limited |
Thiazopyrimidinones and uses thereof
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
ES2395705T3
(es)
|
2008-07-25 |
2013-02-14 |
Glaxosmithkline Llc |
Compuestos químicos
|
CN105198804B
(zh)
|
2008-07-25 |
2018-03-23 |
盐野义制药株式会社 |
用作hiv整合酶抑制剂的化合物
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP2320908B9
(en)
|
2008-07-25 |
2014-06-18 |
VIIV Healthcare Company |
Dolutegravir Prodrugs
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
EA201170537A1
(ru)
|
2008-10-06 |
2011-12-30 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы вич-интегразы
|
TWI432436B
(zh)
|
2008-12-09 |
2014-04-01 |
Gilead Sciences Inc |
類鐸受體的調節劑
|
BRPI0923217A2
(pt)
|
2008-12-11 |
2017-05-23 |
Glaxosmithkline Llc |
processos para a preparação de um composto de piridona, e para a preparação de uma forma cristalina, composto, sal ou um hidrato deste, forma cristalina de um sal de sódio ou um hidrato deste, e, composição farmacêutica.
|
JP2012516333A
(ja)
|
2009-01-28 |
2012-07-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Hivインテグラーゼ阻害剤としての架橋化合物
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
LT2444400T
(lt)
|
2009-06-15 |
2018-06-11 |
Shionogi & Co., Ltd. |
Pakeistasis policiklinis karbamoilpiridono darinys
|
WO2011011483A1
(en)
|
2009-07-22 |
2011-01-27 |
Glaxosmithkline Llc |
Chemical compounds
|
EP2470014A4
(en)
|
2009-08-26 |
2013-01-16 |
Merck Sharp & Dohme |
HIV integrase inhibitors
|
AU2010305805B2
(en)
|
2009-10-13 |
2014-04-03 |
Elanco Animal Health Ireland Limited |
Macrocyclic integrase inhibitors
|
US20120295898A1
(en)
|
2010-01-27 |
2012-11-22 |
Mark Richard Underwood |
Antiviral Therapy
|
SG183484A1
(en)
|
2010-02-26 |
2012-09-27 |
Japan Tobacco Inc |
1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
|
CN102958935B
(zh)
|
2010-04-02 |
2015-12-09 |
爱尔兰詹森科学公司 |
大环整合酶抑制剂
|
US9216995B2
(en)
|
2010-04-12 |
2015-12-22 |
Shionogi & Co., Ltd. |
Pyridone derivative having integrase inhibitory activity
|
US20130165489A1
(en)
|
2010-05-03 |
2013-06-27 |
The Trustees Of The University Of Pennsylvania |
Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
|
MA34397B1
(fr)
|
2010-07-02 |
2013-07-03 |
Gilead Sciences Inc |
Dérivés d'acide napht-2-ylacétique dans le traitement du sida
|
PE20130525A1
(es)
|
2010-07-02 |
2013-05-05 |
Gilead Sciences Inc |
Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih
|
ES2870006T3
(es)
|
2010-08-05 |
2021-10-26 |
Shionogi & Co |
Procedimiento para producir compuestos que tienen actividad inhibidora de la integrasa del HIV
|
TWI577377B
(zh)
|
2010-09-16 |
2017-04-11 |
Viiv醫療保健公司 |
醫藥組合物
|
EP2632454A1
(en)
|
2010-10-29 |
2013-09-04 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
US8835411B2
(en)
|
2010-12-10 |
2014-09-16 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
CA2833377C
(en)
|
2011-04-21 |
2019-02-12 |
Gilead Sciences, Inc. |
Benzothiazole compounds and their pharmaceutical use
|
WO2013006738A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
WO2013054862A1
(ja)
|
2011-10-12 |
2013-04-18 |
塩野義製薬株式会社 |
インテグラーゼ阻害活性を有する多環性ピリドン誘導体
|
US9399645B2
(en)
|
2011-12-20 |
2016-07-26 |
Boehringer Ingelheim International Gmbh |
Inhibitors of HIV replication
|
PE20141558A1
(es)
|
2012-04-20 |
2014-11-06 |
Gilead Sciences Inc |
Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih
|
AU2013280828B2
(en)
|
2012-06-25 |
2017-03-09 |
Sunpower Corporation |
Brace for solar module array
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
WO2014014933A1
(en)
|
2012-07-20 |
2014-01-23 |
Merck Sharp & Dohme Corp. |
Hiv treatment with amido-substituted pyrimidinone derivatives
|
US8906929B2
(en)
|
2012-08-16 |
2014-12-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
DE102012220513B4
(de)
|
2012-11-12 |
2023-02-16 |
Bayerische Motoren Werke Aktiengesellschaft |
Verfahren und Vorrichtung zur Herstellung eines Druckgussteils
|
WO2014099586A1
(en)
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
MD4841B1
(ro)
|
2012-12-21 |
2023-01-31 |
Gilead Sciences, Inc. |
Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică
|
RU2015131006A
(ru)
|
2012-12-27 |
2017-01-30 |
Джапан Тобакко Инк. |
ЗАМЕЩЕННОЕ ПРОИЗВОДНОЕ СПИРОПИРИДО[1,2-a]ПИРАЗИНА И ЕГО ПРИМЕНЕНИЕ В МЕДИЦИНЕ В КАЧЕСТВЕ ИНГИБИТОРА ИНТЕГРАЗЫ ВИРУСА ИММУНОДЕФИЦИТА ЧЕЛОВЕКА (ВИЧ)
|
US9493479B2
(en)
|
2013-04-16 |
2016-11-15 |
Merck Sharp & Dohme Corp. |
Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors
|
ME02977B
(me)
|
2013-05-17 |
2018-10-20 |
Merck Sharp & Dohme |
Fuzionisana triciklicna heterociklicna jedinjenja као inhibiтori hiv integraze
|
US9951079B2
(en)
|
2013-06-13 |
2018-04-24 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
|
NO2865735T3
(lt)
|
2013-07-12 |
2018-07-21 |
|
|
EP3252058B1
(en)
|
2013-07-12 |
2021-01-20 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
|
WO2015039348A1
(en)
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
EA030695B1
(ru)
|
2013-09-27 |
2018-09-28 |
Мерк Шарп И Доум Корп. |
Замещенные производные хинолизина, которые можно использовать как ингибиторы интегразы вич
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
NO2717902T3
(lt)
|
2014-06-20 |
2018-06-23 |
|
|
WO2016027879A1
(ja)
|
2014-08-22 |
2016-02-25 |
塩野義製薬株式会社 |
インテグラーゼ阻害活性を有する多環性ピリドン誘導体
|
AU2015306779B2
(en)
|
2014-08-27 |
2017-11-02 |
VIIV Healthcare UK (NO.5) Ltd |
Imidazo[1,2-a]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication
|
WO2016090545A1
(en)
|
2014-12-09 |
2016-06-16 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrate inhibitors
|
US10150780B2
(en)
|
2014-12-09 |
2018-12-11 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as HIV integrase inhibitors
|
TWI738321B
(zh)
|
2014-12-23 |
2021-09-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
EP3285582B1
(en)
|
2015-03-26 |
2020-11-11 |
Merck Sharp & Dohme Corp. |
Phosphate-substituted quinolizine derivatives useful as hiv integrase inhibitors
|
SG11201707905WA
(en)
|
2015-04-02 |
2017-10-30 |
Gilead Sciences Inc |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
WO2016187788A1
(en)
|
2015-05-25 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds useful for treating hiv infection
|
US10624912B2
(en)
|
2015-11-17 |
2020-04-21 |
Merck Sharp & Dohme Corp. |
Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors
|
WO2017087257A1
(en)
|
2015-11-17 |
2017-05-26 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors
|
US10544155B2
(en)
|
2015-12-15 |
2020-01-28 |
Merck Sharp & Dohme Corp. |
Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors
|
WO2017113288A1
(en)
|
2015-12-31 |
2017-07-06 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
|
EP4299133A3
(en)
|
2016-06-23 |
2024-03-13 |
VIIV Healthcare Company |
Compositions and methods for the delivery of therapeutics
|
JOP20190130A1
(ar)
|
2016-12-02 |
2019-06-02 |
Merck Sharp & Dohme |
مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
|
RU2749043C2
(ru)
|
2016-12-02 |
2021-06-03 |
Мерк Шарп И Доум Корп. |
Трициклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич
|
WO2018109786A1
(en)
|
2016-12-16 |
2018-06-21 |
Cipla Limited |
Novel polymoprphs and salts of polycyclic carbamoyl pyridone derivatives
|
EP3573984A4
(en)
|
2017-01-26 |
2020-07-29 |
Merck Sharp & Dohme Corp. |
USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
|
EP3684767B1
(en)
|
2017-09-22 |
2024-04-24 |
Jubilant Epipad LLC |
Heterocyclic compounds as pad inhibitors
|
CN111970949A
(zh)
|
2018-02-13 |
2020-11-20 |
冷蒸汽解决方案公司 |
用于对气流进行加湿和冷却的方法及组合物
|
WO2019160783A1
(en)
*
|
2018-02-15 |
2019-08-22 |
Merck Sharp & Dohme Corp. |
Tricyclic heterocycle compounds useful as hiv integrase inhibitors
|
WO2019209667A1
(en)
|
2018-04-27 |
2019-10-31 |
Merck Sharp & Dohme Corp. |
Tricyclic heterocycle compounds useful as hiv integrase inhibitors
|
CN110526930B
(zh)
|
2018-05-23 |
2022-06-03 |
莫云芬 |
抗hiv病毒的含硫多环-羟基吡啶酮甲酰胺类似物及其应用
|
EP4257137A3
(en)
|
2018-05-31 |
2023-11-01 |
Shionogi & Co., Ltd |
Polycyclic carbamoylpyridone derivatives for the treatment of hiv
|
MA52802A
(fr)
|
2018-05-31 |
2021-04-14 |
Shionogi & Co |
Dérivé de pyridone polycyclique
|
JP7394074B2
(ja)
|
2018-05-31 |
2023-12-07 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
治療用化合物
|
EP3801543A4
(en)
|
2018-06-05 |
2022-03-02 |
Merck Sharp & Dohme Corp. |
HETEROCYCLIC TRICYCLIC COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
|
WO2019244066A2
(en)
|
2018-06-19 |
2019-12-26 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
WO2020003093A1
(en)
|
2018-06-25 |
2020-01-02 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
WO2020004443A1
(ja)
|
2018-06-27 |
2020-01-02 |
国立大学法人北海道大学 |
多環性カルバモイルピリドン誘導体を含有するアレナウイルス増殖阻害剤
|
MX2021004679A
(es)
|
2018-10-22 |
2021-07-15 |
Univ Nebraska |
Profarmacos antivirales y nanoformulaciones de las mismas.
|
EP3886863A4
(en)
|
2018-11-29 |
2023-01-04 |
Board of Regents of the University of Nebraska |
ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF
|
MX2021011394A
(es)
|
2019-03-22 |
2021-10-13 |
Gilead Sciences Inc |
Compuestos de carbamoilpiridona triciclica puenteada y su uso farmaceutico.
|
CN113795491A
(zh)
|
2019-04-30 |
2021-12-14 |
上海拓界生物医药科技有限公司 |
桥环-3,4-二氢-吡啶并[1,2-a]吡嗪-1,8-二酮化合物及其药物用途
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
TW202120510A
(zh)
|
2019-11-13 |
2021-06-01 |
大陸商上海拓界生物醫藥科技有限公司 |
新型四環雜環化合物及其藥物用途
|
WO2021107065A1
(ja)
|
2019-11-28 |
2021-06-03 |
塩野義製薬株式会社 |
多環性ピリドピラジン誘導体
|
TW202133858A
(zh)
|
2019-11-28 |
2021-09-16 |
日商鹽野義製藥股份有限公司 |
以組合整合酶阻礙劑及抗hiv藥為特徵之hiv感染症的預防及治療用醫藥
|
JP7453399B2
(ja)
|
2020-02-24 |
2024-03-19 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hiv感染症を治療するための四環式化合物及びその使用
|
CN116390924A
(zh)
|
2020-09-30 |
2023-07-04 |
吉利德科学公司 |
桥连三环氨基甲酰基吡啶酮化合物及其用途
|
WO2022159387A1
(en)
*
|
2021-01-19 |
2022-07-28 |
Gilead Sciences, Inc. |
Substituted pyridotriazine compounds and uses thereof
|
AU2022223241A1
(en)
|
2021-02-16 |
2023-08-24 |
Merck Sharp & Dohme Llc |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|